Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2517 -0.1227%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Takeda Pharmaceutical Co Ltd

Add to Portfolio

4502:JP

3,300 JPY 75 2.33%

As of 02:00:00 ET on 05/25/2012.

Snapshot for Takeda Pharmaceutical Co Ltd (4502)

Open: 3,270 Day's Range: 3,260 - 3,310 Volume: 1,990,200 Bid: 2,600
Previous Close: 3,225 52wk Range: 3,005 - 3,875 1-Yr Rtn: -8.82% Ask: -

Stock Chart for 4502

No chart data available.
  • 4502:JP 3,275
  • 1D
  • 1M
  • 1Y
3,225
Interactive 4502 Chart

Previous Close

Key Statistics for 4502

Current P/E Ratio (ttm) 20.9810
Estimated P/E (03/2013) 11.4657
Earnings Per Share (JPY) (ttm) 157.2850
Est. EPS (JPY) (03/2013) 287.8140
Est. PEG Ratio -
Market Cap (M JPY) 2,605,898.00
Shares Outstanding (M) 789.67
Enterprise Value (M JPY) (ttm) 2,769,067.11
Enterprise Value/EBITDA (ttm) 6.67
Price/Book (mrq) 1.2945
Price/Sale (ttm) 1.7264
Dividend Indicated Gross Yield 5.4545
Next Earnings Announcement 07/27/2012
More 4502 Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for 4502

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)
More 4502 Income Statement Data
  • Total Assets
  • Total Liabilities (M/JPY)
  • Debt to Assets (%)
More 4502 Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/JPY)
More 4502 Cash Flow Data

Company Profile & Key Executives for 4502

Takeda Pharmaceutical Company Limited mainly manufactures and sells pharmaceuticals, food supplements, and chemical products like polyurethane. The Company also produces food, agrochemicals, and environment-related products such as pollution detectors. Takeda Pharmaceutical researches, develops, and promotes the products through its related companies in the US, Europe, and Asia.

Yasuchika HasegawaPresidentToyoji YoshidaCAO/Managing Director
Shigenori OhkawaChief Scientific Ofcr/DirectorYasuhiko YamanakaManaging Director
More Company Profile & Key Executives for 4502

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements